{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T21:36:48Z","timestamp":1765057008536},"reference-count":54,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,3]]},"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>Cerebral microbleeds (CMBs) may be markers of intracerebral bleeding risk in patients receiving antithrombotic drugs. This study aimed to analyze CMBs and white matter hyperintensities (WMHs) in patients taking aspirin or clopidogrel.<\/jats:p>\n            <jats:p>This retrospective study included patients with ischemic cardiovascular disease administered 75\u200amg\/day aspirin (n\u200a=\u200a150) or clopidogrel (n\u200a=\u200a150, matched for age and gender) for &gt;1 year (Affiliated Hospital of Inner Mongolia Medical University, China, from July, 2010 to July, 2015). Patients underwent T2-weighted imaging, T1-weighted imaging, diffusion-weighted imaging (DWI) and enhanced T2\u2217-weighted angiography (ESWAN) imaging (3.0-Tesla scanner). Baseline vascular risk factors for CMBs and macroscopic bleeding (MB) were evaluated using univariate and multivariate analyses.<\/jats:p>\n            <jats:p>The aspirin and clopidogrel groups did not differ significantly in baseline characteristics or prevalences of CMBs or MB. The odds of MB were higher in patients with CMBs than in patients without CMBs in both the aspirin (odds ratio, 95% confidence interval: 4.09, 1.93\u20138.68; <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.001) and clopidogrel (6.42, 2.83\u201314.57; <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.001) groups. The odds of WMHs were also higher in patients with CMBs in both the aspirin (3.28, 1.60\u20136.71; <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.001) and clopidogrel (4.09, 1.91\u20138.75; <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.001) groups. Patients receiving treatment for &gt;5 years showed elevated risk of CMBs in the aspirin (0.17; 0.09\u20130.36; <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.001) and clopidogrel (0.15, 0.07\u20130.33; <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.001) groups as well as higher odds of MB in the aspirin (0.34, 0.16\u20130.71; <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.004) and clopidogrel (0.37, 0.17\u20130.80; <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.010) groups.<\/jats:p>\n            <jats:p>The WMHs and MB were associated with CMBs in patients taking aspirin or clopidogrel for &gt;1 year, and long-term use increased the risks of CMB and bleeding.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000014685","type":"journal-article","created":{"date-parts":[[2019,2,28]],"date-time":"2019-02-28T20:42:28Z","timestamp":1551386548000},"page":"e14685","source":"Crossref","is-referenced-by-count":9,"title":["Cerebral microbleeds in patients with ischemic cerebrovascular disease taking aspirin or clopidogrel"],"prefix":"10.1097","volume":"98","author":[{"given":"Lihong","family":"Ge","sequence":"first","affiliation":[{"name":"Department of Magnetic Resonance"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuehui","family":"Ouyang","sequence":"additional","affiliation":[{"name":"Department of Magnetic Resonance, Inner Mongolia Autonomous Region People's Hospital, Hohhot, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Ban","sequence":"additional","affiliation":[{"name":"Department of Magnetic Resonance"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haixia","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Magnetic Resonance"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiong","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Magnetic Resonance"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Magnetic Resonance"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junguo","family":"Liang","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, the Affiliated Hospital of Inner Mongolia Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230914","doi-asserted-by":"crossref","first-page":"2.165","DOI":"10.1016\/S1474-4422(09)70013-4","article-title":"Cerebral microbleeds: a guide to detection and interpretation","volume":"8","author":"Greenberg","year":"2009","journal-title":"Lancet Neurol"},{"key":"R2-20230914","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3389\/fneur.2013.00205","article-title":"Cerebral microbleeds: a review of clinical, genetic, and neuroimaging associations","volume":"4","author":"Yates","year":"2014","journal-title":"Front Neurol"},{"key":"R3-20230914","doi-asserted-by":"crossref","first-page":"1.272","DOI":"10.1148\/radiol.2481071158","article-title":"Cerebral microbleeds: accelerated 3D T2\u2217-weighted GRE MR imaging versus conventional 2D T2\u2217-weighted GRE MR imaging for detection","volume":"248","author":"Vernooij","year":"2008","journal-title":"Radiology"},{"key":"R4-20230914","doi-asserted-by":"crossref","first-page":"6.1238","DOI":"10.1016\/j.ejrad.2011.02.057","article-title":"Susceptibility-weighted angiography (SWAN) of cerebral veins and arteries compared to TOF-MRA","volume":"81","author":"Boeckh-Behrens","year":"2012","journal-title":"Eur J Radiol"},{"key":"R5-20230914","doi-asserted-by":"crossref","first-page":"4.508","DOI":"10.1007\/s00415-006-0406-6","article-title":"Initial microbleeds at MR imaging can predict recurrent intracerebral hemorrhage","volume":"254","author":"Jeon","year":"2007","journal-title":"J Neurol"},{"key":"R6-20230914","doi-asserted-by":"crossref","first-page":"6.1415","DOI":"10.1161\/01.STR.0000126807.69758.0e","article-title":"Hemorrhage burden predicts recurrent intracerebral hemorrhage after lobar hemorrhage","volume":"35","author":"Greenberg","year":"2004","journal-title":"Stroke"},{"key":"R7-20230914","doi-asserted-by":"crossref","first-page":"10.825","DOI":"10.1016\/j.clineuro.2009.08.011","article-title":"Cerebral microbleeds predict first-ever symptomatic cerebrovascular events","volume":"111","author":"Nishikawa","year":"2009","journal-title":"Clin Neurol Neurosurg"},{"key":"R8-20230914","doi-asserted-by":"crossref","first-page":"9308.769","DOI":"10.1016\/S0140-6736(02)07911-4","article-title":"Microbleeds may predict cerebral bleeding after stroke","volume":"359","author":"Senior","year":"2002","journal-title":"Lancet"},{"key":"R9-20230914","doi-asserted-by":"crossref","first-page":"3.272","DOI":"10.1179\/016164107X251556","article-title":"Silent cerebral microbleeds on susceptibility-weighted imaging of patients with ischemic stroke and leukoaraiosis","volume":"30","author":"Gao","year":"2008","journal-title":"Neurol Res"},{"key":"R10-20230914","doi-asserted-by":"crossref","first-page":"6.790","DOI":"10.1001\/archneur.65.6.790","article-title":"Microbleed topography, leukoaraiosis, and cognition in probable Alzheimer disease from the Sunnybrook dementia study","volume":"65","author":"Pettersen","year":"2008","journal-title":"Arch Neurol"},{"issue":"(10 Suppl.)","key":"R11-20230914","first-page":"S103","article-title":"Prevalence and risk factors of cerebral microbleeds: an update of the Rotterdam scan study","volume":"41","author":"Poels","year":"2010","journal-title":"Stroke"},{"key":"R12-20230914","doi-asserted-by":"crossref","first-page":"9.1002","DOI":"10.1136\/jnnp.2007.121913","article-title":"Cerebral microbleeds in the population based AGES-Reykjavik study: prevalence and location","volume":"79","author":"Sveinbjornsdottir","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R13-20230914","doi-asserted-by":"crossref","first-page":"3.720","DOI":"10.2214\/AJR.07.2249","article-title":"MRI of cerebral microhemorrhages","volume":"189","author":"Blitstein","year":"2007","journal-title":"AJR Am J Roentgenol"},{"key":"R14-20230914","doi-asserted-by":"crossref","first-page":"1.67","DOI":"10.1161\/hs0102.100885","article-title":"Cerebral microbleeds in CADASIL: a gradient-echo magnetic resonance imaging and autopsy study","volume":"33","author":"Dichgans","year":"2002","journal-title":"Stroke"},{"key":"R15-20230914","doi-asserted-by":"crossref","first-page":"8.1831","DOI":"10.1161\/01.STR.0000131809.35202.1b","article-title":"Cerebral microbleeds: prevalence and associations with cardiovascular risk factors in the Framingham Study","volume":"35","author":"Jeerakathil","year":"2004","journal-title":"Stroke"},{"key":"R16-20230914","doi-asserted-by":"crossref","first-page":"12.2982","DOI":"10.1161\/ATVBAHA.111.234948","article-title":"Serum lipid levels and the risk of intracerebral hemorrhage: the Rotterdam Study","volume":"31","author":"Wieberdink","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R17-20230914","doi-asserted-by":"crossref","first-page":"1.46","DOI":"10.4103\/2470-7511.248374","article-title":"Cardiovascular diseases in China \u2013 the Blue Book. Myocardial infarction (part two)","volume":"2","author":"Huo","year":"2017","journal-title":"Cardiol Plus"},{"key":"R18-20230914","doi-asserted-by":"crossref","first-page":"6.691","DOI":"10.1001\/archneurol.2009.85","article-title":"Cerebral microbleeds: evidence of heightened risk associated with aspirin use","volume":"66","author":"Gorelick","year":"2009","journal-title":"Arch Neurol"},{"key":"R19-20230914","first-page":"9678.1849","article-title":"Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials","volume":"373","author":"Antithrombotic Trialists","year":"2009","journal-title":"Lancet"},{"key":"R20-20230914","doi-asserted-by":"crossref","first-page":"4.684","DOI":"10.1227\/01.NEU.0000351769.39990.16","article-title":"Reduced platelet activity is associated with more intraventricular hemorrhage","volume":"65","author":"Naidech","year":"2009","journal-title":"Neurosurgery"},{"key":"R21-20230914","doi-asserted-by":"crossref","first-page":"6.714","DOI":"10.1001\/archneurol.2009.42","article-title":"Use of antithrombotic drugs and the presence of cerebral microbleeds: the Rotterdam Scan Study","volume":"66","author":"Vernooij","year":"2009","journal-title":"Arch Neurol"},{"key":"R22-20230914","doi-asserted-by":"crossref","first-page":"6.1222","DOI":"10.1161\/STROKEAHA.109.572594","article-title":"Antithrombotic drug use, cerebral microbleeds, and intracerebral hemorrhage: a systematic review of published and unpublished studies","volume":"41","author":"Lovelock","year":"2010","journal-title":"Stroke"},{"key":"R23-20230914","doi-asserted-by":"crossref","first-page":"6.679","DOI":"10.1136\/jnnp.2009.198994","article-title":"Brain microbleeds as a potential risk factor for antiplatelet-related intracerebral haemorrhage: hospital-based, case-control study","volume":"81","author":"Gregoire","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R24-20230914","doi-asserted-by":"crossref","first-page":"11.1679","DOI":"10.1007\/s00415-008-0967-7","article-title":"Risk vs benefit of anti-thrombotic therapy in ischaemic stroke patients with cerebral microbleeds","volume":"255","author":"Soo","year":"2008","journal-title":"J Neurol"},{"key":"R25-20230914","doi-asserted-by":"crossref","first-page":"8.1483","DOI":"10.3174\/ajnr.A1120","article-title":"Association between cerebral microbleeds on T2\u2217-weighted MR images and recurrent hemorrhagic stroke in patients treated with warfarin following ischemic stroke","volume":"29","author":"Ueno","year":"2008","journal-title":"AJNR Am J Neuroradiol"},{"key":"R26-20230914","doi-asserted-by":"crossref","first-page":"11.3638","DOI":"10.1161\/STROKEAHA.109.559450","article-title":"Cerebral microbleeds in ischemic stroke patients on warfarin treatment","volume":"40","author":"Orken","year":"2009","journal-title":"Stroke"},{"key":"R27-20230914","doi-asserted-by":"crossref","first-page":"8.333","DOI":"10.2176\/nmc.49.333","article-title":"Cerebral microbleeds in patients with intracerebral hemorrhage are associated with previous cerebrovascular diseases and white matter hyperintensity, but not with regular use of antiplatelet agents","volume":"49","author":"Nishikawa","year":"2009","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"R28-20230914","doi-asserted-by":"crossref","first-page":"5.1492","DOI":"10.1161\/STROKEAHA.114.004130","article-title":"Risk factors, stroke prevention treatments, and prevalence of cerebral microbleeds in the Framingham Heart Study","volume":"45","author":"Romero","year":"2014","journal-title":"Stroke"},{"key":"R29-20230914","doi-asserted-by":"crossref","first-page":"12.123","DOI":"10.1007\/s11886-016-0803-0","article-title":"Recent advances in leukoaraiosis: white matter structural integrity and functional outcomes after acute ischemic stroke","volume":"18","author":"Etherton","year":"2016","journal-title":"Curr Cardiol Rep"},{"key":"R30-20230914","doi-asserted-by":"crossref","first-page":"c3666","DOI":"10.1136\/bmj.c3666","article-title":"The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis","volume":"341","author":"Debette","year":"2010","journal-title":"BMJ"},{"key":"R31-20230914","doi-asserted-by":"crossref","first-page":"5.537","DOI":"10.1007\/s00415-004-0359-6","article-title":"Cerebral microbleeds and white matter changes in patients hospitalized with lacunar infarcts","volume":"251","author":"Fan","year":"2004","journal-title":"J Neurol"},{"key":"R32-20230914","doi-asserted-by":"crossref","first-page":"6.1536","DOI":"10.1161\/01.STR.0000018012.65108.86","article-title":"Silent cerebral microbleeds on T2\u2217-weighted MRI: correlation with stroke subtype, stroke recurrence, and leukoaraiosis","volume":"33","author":"Kato","year":"2002","journal-title":"Stroke"},{"key":"R33-20230914","doi-asserted-by":"crossref","first-page":"4.302","DOI":"10.1016\/j.jstrokecerebrovasdis.2009.12.010","article-title":"Age-related changes in white matter lesions, hippocampal atrophy, and cerebral microbleeds in healthy subjects without major cerebrovascular risk factors","volume":"20","author":"Chowdhury","year":"2011","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"R34-20230914","doi-asserted-by":"crossref","first-page":"1.98","DOI":"10.1111\/j.1468-1331.2011.03451.x","article-title":"Periventricular and deep white matter leukoaraiosis have a closer association with cerebral microbleeds than age","volume":"19","author":"Yamada","year":"2012","journal-title":"Eur J Neurol"},{"key":"R35-20230914","doi-asserted-by":"crossref","first-page":"12.2845","DOI":"10.1161\/01.STR.0000036092.23649.2E","article-title":"Low concentration of serum total cholesterol is associated with multifocal signal loss lesions on gradient-echo magnetic resonance imaging: analysis of risk factors for multifocal signal loss lesions","volume":"33","author":"Lee","year":"2002","journal-title":"Stroke"},{"key":"R36-20230914","doi-asserted-by":"crossref","first-page":"2.351","DOI":"10.2214\/ajr.149.2.351","article-title":"MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging","volume":"149","author":"Fazekas","year":"1987","journal-title":"AJR Am J Roentgenol"},{"key":"R37-20230914","doi-asserted-by":"crossref","first-page":"10.2236","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.05.022","article-title":"Antiplatelet drug use and cerebral microbleeds: a meta-analysis of published studies","volume":"24","author":"Liu","year":"2015","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"R38-20230914","doi-asserted-by":"crossref","first-page":"6.494","DOI":"10.1016\/S1474-4422(08)70094-2","article-title":"Cilostazol as an alternative to aspirin after ischaemic stroke: a randomised, double-blind, pilot study","volume":"7","author":"Huang","year":"2008","journal-title":"Lancet Neurol"},{"key":"R39-20230914","doi-asserted-by":"crossref","first-page":"8.624","DOI":"10.1016\/j.amjmed.2005.10.039","article-title":"Systematic review and meta-analysis of adverse events of low-dose aspirin and clopidogrel in randomized controlled trials","volume":"119","author":"McQuaid","year":"2006","journal-title":"Am J Med"},{"key":"R40-20230914","first-page":"6.441","article-title":"Aspirin- and clopidogrel-associated bleeding complications: data mining of the public version of the FDA adverse event reporting system, AERS","volume":"9","author":"Tamura","year":"2012","journal-title":"Int J Med Sci"},{"key":"R41-20230914","doi-asserted-by":"crossref","first-page":"6.834","DOI":"10.1016\/j.jstrokecerebrovasdis.2012.06.001","article-title":"Antiplatelet therapy as a risk factor for microbleeds in intracerebral hemorrhage patients: analysis using specific antiplatelet agents","volume":"22","author":"Naka","year":"2013","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"R42-20230914","doi-asserted-by":"crossref","first-page":"2.105","DOI":"10.1016\/j.jstrokecerebrovasdis.2009.11.007","article-title":"Clinical correlating factors and cognitive function in community-dwelling healthy subjects with cerebral microbleeds","volume":"20","author":"Takashima","year":"2011","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"R43-20230914","doi-asserted-by":"crossref","first-page":"3.656","DOI":"10.1161\/STROKEAHA.110.607184","article-title":"Incidence of cerebral microbleeds in the general population: the Rotterdam Scan Study","volume":"42","author":"Poels","year":"2011","journal-title":"Stroke"},{"key":"R44-20230914","first-page":"1.88","article-title":"Brain microhemorrhages detected on T2\u2217-weighted gradient-echo MR images","volume":"24","author":"Tsushima","year":"2003","journal-title":"AJNR Am J Neuroradiol"},{"key":"R45-20230914","doi-asserted-by":"crossref","first-page":"3.214","DOI":"10.1016\/j.jstrokecerebrovasdis.2009.12.001","article-title":"Clinical characteristics by topographical distribution of brain microbleeds, with a particular emphasis on diffuse microbleeds","volume":"20","author":"Yakushiji","year":"2011","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"R46-20230914","first-page":"3e91637","article-title":"Cerebral microbleeds are associated with deep white matter hyperintensities, but only in hypertensive patients","volume":"9","author":"Gao","year":"2014","journal-title":"PLoS One"},{"key":"R47-20230914","doi-asserted-by":"crossref","first-page":"6.863","DOI":"10.1017\/S0317167100012440","article-title":"Aspirin treatment increases the risk of cerebral microbleeds","volume":"38","author":"Ge","year":"2011","journal-title":"Can J Neurol Sci"},{"key":"R48-20230914","doi-asserted-by":"crossref","first-page":"7.1923","DOI":"10.1161\/STROKEAHA.116.012734","article-title":"Differential effect of white-matter lesions and covert brain infarcts on the risk of ischemic stroke and intracerebral hemorrhage","volume":"47","author":"Kaffashian","year":"2016","journal-title":"Stroke"},{"key":"R49-20230914","doi-asserted-by":"crossref","first-page":"3.433","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.03.027","article-title":"Associations of durations of antiplatelet use and vascular risk factors with the presence of cerebral microbleeds","volume":"23","author":"Yamashiro","year":"2014","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"R50-20230914","doi-asserted-by":"crossref","first-page":"1-2.56","DOI":"10.1016\/j.jns.2012.05.017","article-title":"No significant association of aspirin use with cerebral microbleeds in the asymptomatic elderly","volume":"319","author":"Kim","year":"2012","journal-title":"J Neurol Sci"},{"key":"R51-20230914","first-page":"1.104","article-title":"Administration of a loading dose has no additive effect on platelet aggregation during the switch from ongoing clopidogrel treatment to ticagrelor in patients with acute coronary syndrome","volume":"7","author":"Caiazzo","year":"2014","journal-title":"Circ Cardiovasc Interv"},{"key":"R52-20230914","doi-asserted-by":"crossref","first-page":"13.1277","DOI":"10.1016\/j.jcin.2018.01.263","article-title":"Platelet reactivity and risk of ischemic stroke after coronary drug-eluting stent implantation: from the ADAPT-DES study","volume":"11","author":"Giustino","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"R53-20230914","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ejps.2018.03.011","article-title":"Pharmacometabolomics analysis of plasma to phenotype clopidogrel high on treatment platelets reactivity in coronary artery disease patients","volume":"117","author":"Amin","year":"2018","journal-title":"Eur J Pharm Sci"},{"key":"R54-20230914","doi-asserted-by":"crossref","first-page":"3968206","DOI":"10.1155\/2016\/3968206","article-title":"Modulation of circulating microRNAs levels during the switch from clopidogrel to ticagrelor","volume":"2016","author":"Carino","year":"2016","journal-title":"Biomed Res Int"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00005792-201903010-00041","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T18:38:40Z","timestamp":1694716720000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201903010-00041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":54,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000014685","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3]]}}}